Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02535806
Title Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Mercy Hospital Kansas City
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.